Austedo's drug class is a vmat2 inhibitor (vesicular monoamine transporter 2 inhibitor) See safety info and boxed warning. What is tardive dyskinesia (td) and chorea associated with huntington’s disease
Social media sensation Nick Yardy reflects on how he created a multimillion dollar empire
2.1 dosing information the dose of austedo xr and austedo is determined individually for each patient based on reduction of chorea or tardive dyskinesia and tolerability
Table 1 displays the recommended dosage and important administration instructions of austedo xr and austedo when first prescribed to patients who are not being switched from tetrabenazine (a related vmat2 inhibitor).
In a cohort of 27 participants, up to 77% reported enhancements in daily activities such as speech and eating after three months of treatment. Learn about uses, side effects, and more for austedo (deutetrabenazine), a drug that treats tardive dyskinesia and chorea related to huntington’s disease. Reduce involuntary movements with austedo xr® (deutetrabenazine) tablets treatment for td
